UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 379

Sortiert nach

Signaling pathways essential for triple‐negative breast cancer stem‐like cells

Stem cells (Dayton, Ohio), 2021-02, Vol.39 (2), p.133-143

2021

Volltextzugriff (PDF)

Hypoxia induces HIF1α-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy

Nature communications, 2022-07, Vol.13 (1), p.4118-4118, Article 4118

2022

Volltextzugriff (PDF)

Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer

Nature communications, 2017-09, Vol.8 (1), p.410-14, Article 410

2017

Volltextzugriff (PDF)

Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC

JNCI : Journal of the National Cancer Institute, 2017-09, Vol.109 (9)

2017

Volltextzugriff (PDF)

Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer

Nature communications, 2021-08, Vol.12 (1), p.5112-5112, Article 5112

2021

Volltextzugriff (PDF)

EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy

Nature communications, 2020-11, Vol.11 (1), p.5878-5878, Article 5878

2020

Volltextzugriff (PDF)

SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer

Breast cancer research : BCR, 2018-06, Vol.20 (1), p.60-60, Article 60

2018

Volltextzugriff (PDF)

Anti-human CD73 monoclonal antibody inhibits metastasis formation in human breast cancer by inducing clustering and internalization of CD73 expressed on the surface of cancer cells

The Journal of immunology (1950), 2013-10, Vol.191 (8), p.4165-4173

2013

Volltextzugriff (PDF)

Plasma Membrane Proteomics and Its Application in Clinical Cancer Biomarker Discovery

Molecular & cellular proteomics, 2010-07, Vol.9 (7), p.1369-1382

2010

Volltextzugriff (PDF)

KeyPathwayMinerWeb: online multi-omics network enrichment

Nucleic acids research, 2016-07, Vol.44 (W1), p.W98

2016

Volltextzugriff (PDF)

DDX56 modulates post-transcriptional Wnt signaling through miRNAs and is associated with early recurrence in squamous cell lung carcinoma

Molecular cancer, 2021-08, Vol.20 (1), p.108-108, Article 108

2021

Volltextzugriff (PDF)

Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer

Breast cancer research : BCR, 2021-02, Vol.23 (1), p.26-18, Article 26

2021

Volltextzugriff (PDF)

Adoptive cancer immunotherapy using DNA-demethylated T helper cells as antigen-presenting cells

Nature communications, 2018-03, Vol.9 (1), p.785-12, Article 785

2018

Volltextzugriff (PDF)

Downregulation of antigen presentation-associated pathway proteins is linked to poor outcome in triple-negative breast cancer patient tumors

Oncoimmunology, 2017-05, Vol.6 (5), p.e1305531-e1305531

2017

Volltextzugriff (PDF)

The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer

Breast cancer research and treatment, 2012-07, Vol.134 (1), p.207-217

2012

Volltextzugriff (PDF)

Efficient Isolation and Quantitative Proteomic Analysis of Cancer Cell Plasma Membrane Proteins for Identification of Metastasis-Associated Cell Surface Markers

Journal of proteome research, 2009-06, Vol.8 (6), p.3078-3090

2009

Volltextzugriff (PDF)

S100A14 is a novel independent prognostic biomarker in the triple‐negative breast cancer subtype

International journal of cancer, 2015-11, Vol.137 (9), p.2093-2103

2015

Volltextzugriff (PDF)

Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer

Nature communications, 2021-09, Vol.12 (1), p.5588-5588, Article 5588

2021

Volltextzugriff (PDF)

NADH-Cytochrome b5 Reductase 3 Promotes Colonization and Metastasis Formation and Is a Prognostic Marker of Disease-Free and Overall Survival in Estrogen Receptor-Negative Breast Cancer

Molecular & cellular proteomics, 2015-11, Vol.14 (11), p.2988-2999

2015

Volltextzugriff (PDF)

Oncogenic cancer/testis antigens: prime candidates for immunotherapy

Oncotarget, 2015-06, Vol.6 (18), p.15772-15787

2015

Volltextzugriff (PDF)

Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

Oncogene, 2020-03, Vol.39 (10), p.2229-2230

2020

Volltextzugriff (PDF)

Metastasis-related Plasma Membrane Proteins of Human Breast Cancer Cells Identified by Comparative Quantitative Mass Spectrometry

Molecular & cellular proteomics, 2009-06, Vol.8 (6), p.1436-1449

2009

Volltextzugriff (PDF)

Effects of Arsenite Exposure during Fetal Development on Energy Metabolism and Susceptibility to Diet-Induced Fatty Liver Disease in Male Mice

Environmental health perspectives, 2016-02, Vol.124 (2), p.201-209

2016

Volltextzugriff (PDF)

Autoantibodies against C1q in Systemic Lupus Erythematosus Are Antigen-Driven

The Journal of immunology (1950), 2009-12, Vol.183 (12), p.8225-8231

2009

Volltextzugriff (PDF)

How to increase value and reduce waste in research: initial experiences of applying Lean thinking and visual management in research leadership

BMJ open, 2022-06, Vol.12 (6), p.e058179-e058179

2022

Volltextzugriff (PDF)

1 – 25 von 379

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(259)
Mit Volltextzugriff
(231)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Signaling pathways essential for triple‐negative breast cancer stem‐like cells

Hypoxia induces HIF1α-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy

Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer

Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC

Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer

EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy

SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer

Anti-human CD73 monoclonal antibody inhibits metastasis formation in human breast cancer by inducing clustering and internalization of CD73 expressed on the surface of cancer cells

Plasma Membrane Proteomics and Its Application in Clinical Cancer Biomarker Discovery

KeyPathwayMinerWeb: online multi-omics network enrichment

DDX56 modulates post-transcriptional Wnt signaling through miRNAs and is associated with early recurrence in squamous cell lung carcinoma

Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer

Adoptive cancer immunotherapy using DNA-demethylated T helper cells as antigen-presenting cells

Downregulation of antigen presentation-associated pathway proteins is linked to poor outcome in triple-negative breast cancer patient tumors

The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer

Efficient Isolation and Quantitative Proteomic Analysis of Cancer Cell Plasma Membrane Proteins for Identification of Metastasis-Associated Cell Surface Markers

S100A14 is a novel independent prognostic biomarker in the triple‐negative breast cancer subtype

Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer

NADH-Cytochrome b5 Reductase 3 Promotes Colonization and Metastasis Formation and Is a Prognostic Marker of Disease-Free and Overall Survival in Estrogen Receptor-Negative Breast Cancer

Oncogenic cancer/testis antigens: prime candidates for immunotherapy

Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

Metastasis-related Plasma Membrane Proteins of Human Breast Cancer Cells Identified by Comparative Quantitative Mass Spectrometry

Effects of Arsenite Exposure during Fetal Development on Energy Metabolism and Susceptibility to Diet-Induced Fatty Liver Disease in Male Mice

Autoantibodies against C1q in Systemic Lupus Erythematosus Are Antigen-Driven

How to increase value and reduce waste in research: initial experiences of applying Lean thinking and visual management in research leadership

Aktive Filter

Suchergebnisse filtern